Clinical Analysis of Peripheral Blood Indicators for Immune-Related Adverse Events (irAEs) in Patients With Advanced Lung Cancer
Ji, Yin-Min; Qin, Yu-hui; Lv, Ya-Hui; Xiao, Shu-Yan; Dong, Yi; Hu, Zhi-Song; Cui, Peng-Fei; Li, Tao; Cui, Xiao-Ran; Hu, Yi.png)
Share.png)
Save Retrospective Analysis of the Clinical Efficacy, Safety, and Influencing Factors of Drug-Eluting Bead Transarterial Chemoembolization for Unresectable Hepatic MalignanciesLiu, Li; Sheng, Yuling; Liang, Xianxian; Yang, Tao; Dong, Li; Gao, Dazhi; Chen, Bo; Xu, Tantan; Ai, Min; Shan, Husheng; Tang, Jinjing; Zhang, Longjiang; Shi, Donghong; Zhu, Xiaoli Share Save Symptom Burden and Healthcare Resource Use in Patients With Claudin 18.2-Positive, HER2-Negative, Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma: A Retrospective ReviewSewastjanow-Silva, Matheus; Oh, Mok; Chang, Lawrence; Ganguli, Arijit; Rogers, Jane E.; Waters, Rebecca E.; Vicentini, Ernesto Rosa; Yamashita, Kohei; Totev, Todor, I; Wu, Eric Q.; Yang, Hongbo; Iwata, Kenneth; Ajani, Jaffer A. Share Save 
.png){kind=icon}
Not logged in.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
